121 related articles for article (PubMed ID: 24397554)
1. A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides.
Schittenhelm RB; Dudek NL; Croft NP; Ramarathinam SH; Purcell AW
Tissue Antigens; 2014 Mar; 83(3):174-9. PubMed ID: 24397554
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of peptides presented by HLA-A1.
Giam K; Ayala-Perez R; Illing PT; Schittenhelm RB; Croft NP; Purcell AW; Dudek NL
Tissue Antigens; 2015 Jun; 85(6):492-6. PubMed ID: 25880248
[TBL] [Abstract][Full Text] [Related]
3. Generating data for databases--the peptide repertoire of HLA molecules.
Stevanović S; Lemmel C; Häntschel M; Eberle U
Novartis Found Symp; 2003; 254():143-55; discussion 155-64, 216-22, 250-2. PubMed ID: 14712936
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices.
Di Marco M; Schuster H; Backert L; Ghosh M; Rammensee HG; Stevanović S
J Immunol; 2017 Oct; 199(8):2639-2651. PubMed ID: 28904123
[TBL] [Abstract][Full Text] [Related]
5. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
[TBL] [Abstract][Full Text] [Related]
6. Inefficient assembly limits transport and cell surface expression of HLA-Cw4 molecules in C1R.
Zemmour J
Tissue Antigens; 1996 Dec; 48(6):651-61. PubMed ID: 9008307
[TBL] [Abstract][Full Text] [Related]
7. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.
Zemmour J; Little AM; Schendel DJ; Parham P
J Immunol; 1992 Mar; 148(6):1941-8. PubMed ID: 1541831
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific amplification of the complete HLA-C gene from genomic DNA - a novel Cw4 allele (C*04:71) with a Cw1 motif in the peptide-binding site.
Moraru M; Balas A; de Pablo R; Vicario JL; Vilches C
Tissue Antigens; 2012 Apr; 79(4):291-4. PubMed ID: 22251067
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.
Kessler JH; Bres-Vloemans SA; van Veelen PA; de Ru A; Huijbers IJ; Camps M; Mulder A; Offringa R; Drijfhout JW; Leeksma OC; Ossendorp F; Melief CJ
Leukemia; 2006 Oct; 20(10):1738-50. PubMed ID: 16932347
[TBL] [Abstract][Full Text] [Related]
10. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
[TBL] [Abstract][Full Text] [Related]
11. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs.
Harris PE; Colovai A; Liu Z; Dalla Favera R; Suciu-Foca N
J Immunol; 1993 Dec; 151(11):5966-74. PubMed ID: 8245441
[TBL] [Abstract][Full Text] [Related]
12. Pocketcheck: updating the HLA class I peptide specificity roadmap.
Huyton T; Ladas N; Schumacher H; Blasczyk R; Bade-Doeding C
Tissue Antigens; 2012 Sep; 80(3):239-48. PubMed ID: 22803829
[TBL] [Abstract][Full Text] [Related]
13. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
14. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL
J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850
[TBL] [Abstract][Full Text] [Related]
15. Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cells.
Papadopoulos KP; Hesdorffer CS; Suciu-Foca N; Hibshoosh H; Harris PE
Clin Cancer Res; 1999 Aug; 5(8):2089-93. PubMed ID: 10473091
[TBL] [Abstract][Full Text] [Related]
16. Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini.
Kowalewski DJ; Walz S; Backert L; Schuster H; Kohlbacher O; Weisel K; Rittig SM; Kanz L; Salih HR; Rammensee HG; Stevanović S; Stickel JS
Blood Cancer J; 2016 Apr; 6(4):e411. PubMed ID: 27058226
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of HIV-1 epitopes presented by HLA-A*2603: comparison between HIV-1 epitopes presented by A*2601 and A*2603.
Kawashima Y; Satoh M; Oka S; Takiguchi M
Hum Immunol; 2005 Nov; 66(11):1155-66. PubMed ID: 16571416
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
19. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.
Monji T; McCormack AL; Yates JR; Pious D
J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705
[TBL] [Abstract][Full Text] [Related]
20. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
Hulpke S; Baldauf C; Tampé R
FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
